The Science Behind Lower Dosing Requirements
Why Is Wegovy Dose Lower Than Mounjaro: Mechanism Differences
The fundamental reason why is Wegovy dose lower than Mounjaro relates to their distinct mechanisms of action. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that specifically targets one hormone pathway involved in appetite regulation and satiety. Mounjaro, containing tirzepatide, is a dual agonist that activates both GIP and GLP-1 receptors simultaneously. This dual mechanism requires higher milligram doses to achieve therapeutic effect, whilst Wegovy's targeted approach achieves clinical benefits at lower absolute doses. The maximum maintenance dose for Wegovy is 2.4mg weekly, compared to Mounjaro's 15mg weekly maintenance dose—a six-fold difference in absolute numbers.
However, these dosing differences don't indicate relative potency or effectiveness. Each medication is formulated to achieve optimal receptor binding and clinical response at their respective dose ranges. When patients ask why is Wegovy dose lower than Mounjaro, it's important to understand that both medications undergo extensive dose-escalation protocols over 16-20 weeks to minimise gastrointestinal side effects. The lower absolute numbers for Wegovy simply reflect the pharmacological properties of semaglutide versus tirzepatide. Both are prescription-only medicines requiring careful clinical assessment and monitoring.
Switch & Save: Cost Comparison Between Treatments
Understanding why is Wegovy dose lower than Mounjaro becomes particularly relevant when comparing treatment costs. At EverydayMeds, Wegovy pricing ranges from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose. New customers can apply code FIRST40 at checkout, whilst returning customers use code DOSE25 for optimal pricing. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, providing the first 12 weeks of treatment with convenient single delivery. For patients requiring extended starter dosing, the Gentle Start Trio offers repeated 0.25mg doses plus 0.5mg progression for £269.99.
Many patients switching from Mounjaro to Wegovy report significant cost savings, particularly during maintenance phases. The Ultimate Stability Trio provides three months of 2.4mg maintenance doses for £649.99, ensuring treatment continuity without repeated ordering. Our GPhC-registered pharmacy (#9012878) maintains competitive pricing across all dose strengths, with transparent costs and no hidden fees. The question of why is Wegovy dose lower than Mounjaro often leads to cost considerations, where lower absolute dosing can translate to supply chain efficiencies and potential patient savings.
Clinical Evidence: STEP Trials and Switching Data
When examining why is Wegovy dose lower than Mounjaro, clinical trial evidence provides important context. In the landmark STEP trials, Wegovy demonstrated significant weight management benefits with the established dose escalation protocol. STEP 1 showed approximately 15% average weight loss at 68 weeks versus 2.4% with placebo, when used alongside reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The SELECT trial further demonstrated a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Patients switching between GLP-1 therapies typically maintain clinical benefits when properly transitioned under medical supervision. The lower dosing profile of Wegovy doesn't compromise efficacy—it reflects the medication's pharmacological design. Clinical data suggests that patients may switch between semaglutide and tirzepatide-based treatments based on individual response, tolerability, and practical considerations including cost and convenience.
How Wegovy Works: GLP-1 Receptor Mechanism
To understand why is Wegovy dose lower than Mounjaro, it's essential to grasp how Wegovy functions at the cellular level. Semaglutide is a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones released after eating. When administered, it binds specifically to GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness and reducing food cravings. The medication also slows gastric emptying, meaning food remains in the stomach longer, contributing to sustained satiety. This targeted mechanism allows Wegovy to achieve therapeutic effects at lower milligram doses compared to dual-pathway medications. The once-weekly FlexTouch pen delivers precise doses subcutaneously, with the medication's extended half-life maintaining consistent appetite regulation throughout the week.
Ordering Process: Assessment to Delivery
Getting started with Wegovy through EverydayMeds involves a streamlined three-step process designed for both new patients and those switching from other treatments. The online clinical assessment takes approximately three minutes, covering medical history, current medications, and weight management goals—essential information when considering why is Wegovy dose lower than Mounjaro might benefit your specific situation. Qualified prescribers review applications within three working days (or 24 hours with express service), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, medications ship via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity. Our GPhC-registered pharmacy (#9012878) coordinates seamless transitions for patients switching treatments, with prescribers providing guidance on timing and dose conversion. The entire process prioritises patient safety whilst minimising delays in treatment continuity.
Storage and Practical Advantages
One practical benefit when considering why is Wegovy dose lower than Mounjaro extends to storage requirements and travel convenience. Wegovy can be stored at room temperature (below 30°C) for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for patients who travel frequently or prefer flexible medication management. The FlexTouch pen system is pre-filled and disposable, eliminating the need for separate needles or mixing. The dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance) is clearly marked on each pen, reducing confusion during treatment progression. These practical considerations often influence treatment choice, particularly for patients seeking convenience alongside clinical effectiveness.
Switching Considerations: From Mounjaro to Wegovy
Patients exploring why is Wegovy dose lower than Mounjaro often have switching in mind, seeking either cost savings or different side effect profiles. The transition between tirzepatide and semaglutide requires medical supervision, as the medications have different pharmacokinetic properties and receptor binding profiles. Most prescribers recommend a washout period or gradual transition to minimise potential gastrointestinal adjustment. Cost considerations frequently drive switching decisions, with Wegovy's pricing structure offering potential savings, particularly during maintenance phases. EverydayMeds stocks both medications, enabling seamless pharmacy-level transitions without changing suppliers or delivery arrangements.
Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which medication aligns best with your clinical needs, lifestyle, and budget. Our clinical team can coordinate timing and provide guidance on managing any transition period. The question of why is Wegovy dose lower than Mounjaro ultimately becomes secondary to finding the right treatment approach for individual circumstances, whether that involves switching, continuing current therapy, or exploring combination approaches under medical supervision.
Start Your Switch & Save Journey Today
Understanding why is Wegovy dose lower than Mounjaro empowers informed treatment decisions, particularly when cost considerations influence medication choice. EverydayMeds offers competitive pricing across all Wegovy dose strengths, with bundle options providing additional convenience for longer-term treatment planning. New customers can use code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 for optimal pricing. Our three-minute clinical assessment begins the process, with qualified prescribers available to discuss switching strategies and address questions about dose conversion or treatment timing. With next-day delivery and comprehensive patient support, transitioning to Wegovy becomes straightforward and cost-effective. Visit our weight loss collection to explore options and begin your assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
